🇺🇸 FDA
Pipeline program

VATS

FAHG20081202

Phase 2 other active

Quick answer

VATS for Non-small Cell Lung Cancer is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Non-small Cell Lung Cancer
Phase
Phase 2
Modality
other
Status
active

Clinical trials